Seroprevalence of Toxoplasma gondii among ocular infection patient in Shahid Dr. Aso Hospital in Sulaimani City, Iraq

https://doi.org/10.53730/ijhs.v6nS9.12165

Authors

  • Diyari Othman Karim Mediacal Laboratory department, College of Health & Medical Technology, Sulaimani Polytechinc University, Iraq
  • Kamaran Hasan Azeez Shahid Dr. Aso Eye Teaching Hospital, Sulaimani, Iraq
  • Younis Sabir Abdullah Mediacal Laboratory department, College of Health & Medical Technology, Sulaimani Polytechinc University, Iraq

Keywords:

Toxoplasma gondii, Ocular toxoplasmosis, Serology, Rapid test, ELISA, Color fundus photography, Chorioretinal scar

Abstract

Toxoplasma gondii is an intracellular protozoan parasite that causes ocular toxoplasmosis with most complications such as developing eye lesions and impaired vision. During the period from October 2021 to April 2022, a total of 174 blood samples were taken from ocular infected patients whom visited Shahid Dr. Aso Hospital in Sulaimani City, Iraq. These samples were tested serologically for detection of anti-Toxoplasma gondii antibodies (IgG and IgM) with both imunochromatograhpy (rapid test) and ELISA. The serological test demonstrated that 63 IgG (36.2%) and 4 IgM (2.2%) were positive by rapid test imunochromatograhpy. While, 80 IgG (45.9%) and 2 IgM (1.1%) were positive by ELISA. Most of the infections (58.75%) were between 50-69 years old. All patients (80) were examined for intraocular toxoplasmosis lesion, only 10 patients (12.5%) including 2 males (2.5%) and 8 females (10%) had ocular toxoplasmosis lesions. Most of the lesions were scars (old type) while, in some patients they were active lesions. The types of lesions, numbers per each eye, lesion diameter and comparison with the IgG and IgM titers were demonstrated.

Downloads

Download data is not yet available.

References

Abdulhadi, A.F., Clinical Manifestations of Ocular Toxoplasmosis at a Referral Center in Iraq. Iraqi Postgraduate Medical Journal, 2021. 20(1).

Ajioka, J.W. and N.S. Morrissette, A century of Toxoplasma research. International journal for parasitology, 2009. 39(8): p. 859.

Al-Aubaidi, I.K., A.N. Yaseen, and W.R. Ali, Real-Time PCR detection of Ocular Toxoplasmosis in Iraqi patients. Journal of Madenat Alelem University College, 2017. 9(1): p. 201-216.

Al-Shakarchi, F.I., Pattern of uveitis at a referral center in Iraq. Middle East African journal of ophthalmology, 2014. 21(4): p. 291.

Arshadi, M.A., Lame Meamar, Ahmad Reza Alizadeh Ghavidel, Leila Nasiri, Kamal Mahami-Oskouei, Mahmoud Mousavi, Farideh Rampisheh, Zahra Khanmohammadi, Majid Razmjou, Elham, Sero-molecular detection, multi-locus genotyping, and clinical manifestations of ocular toxoplasmosis in patients in northwest Iran. Transactions of The Royal Society of Tropical Medicine and Hygiene, 2019. 113(4): p. 195-202.

Berengo, A. and R. Frezzotti, Active neuro-ophthalmic toxoplasmosis. A clinical study on nineteen patients. Bibliotheca ophthalmologica: supplementa ad ophthalmologica, 1962. 59: p. 265-343.

Bosch-Driessen, L.E.B., Tos TJM Ongkosuwito, Jenny V Rothova, Aniki, Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology, 2002. 109(5): p. 869-878.

Delair, E.L., Paul Noble, A Gwendolyn Rabiah, Peter McLeod, Rima Brézin, Antoine, Clinical manifestations of ocular toxoplasmosis. Ocular immunology and inflammation, 2011. 19(2): p. 91-102.

De-la-Torre, A.R.-C., AC Cardozo-García, CM Gomez-Marin, JE, Frequency and factors associated with recurrences of ocular toxoplasmosis in a referral centre in Colombia. British journal of ophthalmology, 2009. 93(8): p. 1001-1004.

Döşkaya, M.C., Ayşe Can, Hüseyin Gülçe İz, Sultan Gedik, Yaprak Döşkaya, Aysu Değirmenci Kalantari-Dehaghi, Mina Gürüz, Yüksel, Diagnostic value of a Rec-ELISA using Toxoplasma gondii recombinant SporoSAG, BAG1, and GRA1 proteins in murine models infected orally with tissue cysts and oocysts. PloS one, 2014. 9(9): p. e108329.

Dubey, J.P., Toxoplasmosis of animals and humans. 2016: CRC press.

Friedmann, C.T. and D.L. Knox, Variations in recurrent active toxoplasmic retinochoroiditis. Archives of ophthalmology, 1969. 81(4): p. 481-493.

Hassaneina, F. and A.I. Shehata, Rapid immunochromatographic test (RDT) versus ELISA technique for diagnosing toxoplasmosis among individuals with mental disabilities. International Journal of Innovative Research & Development, 2018. 7: p. 61-66.

Holland, G.N., Ocular toxoplasmosis: a global reassessment: part II: disease manifestations and management. American journal of ophthalmology, 2004. 137(1): p. 1-17.

Holland, G.N., Ocular toxoplasmosis: a global reassessment:. Part I: epidemiology and course of disease. American journal of ophthalmology, 2003. 136(6): p. 973-988.

Hosseini, S.M.M., Elham Sharifi, Karim Dadgar Moghaddam, Malihe Shamsian, Seyed Aliakbar, Assessment of ocular toxoplasmosis patients reported at a tertiary center in the Northeast of Iran. International Ophthalmology, 2018. 38(6): p. 2527-2533.

Jones, J.L.B., Valerie Holland, Gary N Press, Cindy Sanislo, Steven R Khurana, Rahul N Montoya, Jose G, Ocular toxoplasmosis in the United States: recent and remote infections. Clinical Infectious Diseases, 2015. 60(2): p. 271-273.

Khidoyatova, M. R., Kayumov, U. K., Inoyatova, F. K., Fozilov, K. G., Khamidullaeva, G. A., & Eshpulatov, A. S. (2022). Clinical status of patients with coronary artery disease post COVID-19. International Journal of Health & Medical Sciences, 5(1), 137-144. https://doi.org/10.21744/ijhms.v5n1.1858

Lago, E.G.E., Mariana Miranda Scheeren, Marôla Flores da Cunha Fiori, Humberto Holmer, Ocular outcome of Brazilian patients with congenital toxoplasmosis. The Pediatric Infectious Disease Journal, 2020. 40(1): p. e21-e27.

Liu, Q., L.D. Singla, and H. Zhou, Vaccines against Toxoplasma gondii: status, challenges and future directions. Human vaccines & immunotherapeutics, 2012. 8(9): p. 1305-1308.

Liu, Q.W., Ze-Dong Huang, Si-Yang Zhu, Xing-Quan, Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasites & vectors, 2015. 8(1): p. 1-14.

Lynch, M.I.C., Francisco Ferreira, Silvana Ximenes, Ricardo Oréfice, Fernando Malagueño, Elizabeth, Lacrimal secretory IgA in active posterior uveitis induced by Toxoplasma gondii. Memórias do Instituto Oswaldo Cruz, 2004. 99(8): p. 861-864.

Mahmoud, S.F., A.-L. Molan, and M.H. Rathi, Seroprevalence of Toxoplasma gondii infection in children with visual and/or hearing disability in comparison with healthy children in Iraq. Malaysian Journal of Medicine and Health Sciences, 2020. 16(3): p. 140-147.

Mattos, C.C.M., Cristina S Ferreira, Ana IC Frederico, Fábio B Hiramoto, Roberto M Almeida Jr, Gildásio C Mattos, Luiz C Pereira-Chioccola, Vera L, Contribution of laboratory methods in diagnosing clinically suspected ocular toxoplasmosis in Brazilian patients. Diagnostic microbiology and infectious disease, 2011. 70(3): p. 362-366.

Moeed A, K. and K. Younis I, Uveitis in iraqi patients: prevalence of causes and importance of labratory tests. 2008.

Montoya, J.G., Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. The Journal of infectious diseases, 2002. 185(Supplement_1): p. S73-S82.

Morisaki, J.H., J.E. Heuser, and L.D. Sibley, Invasion of Toxoplasma gondii occurs by active penetration of the host cell. Journal of cell science, 1995. 108(6): p. 2457-2464.

Norouzi, L.Y.S., B Asgari, Q Khabisi, S Abdolahi, Molecular evaluation and seroprevalence of toxoplasmosis in pregnant women in Fars province, Southern Iran. Annals of Medical and Health Sciences Research, 2017. 7(1): p. 16-19.

Ozgonul, C. and C.G. Besirli, Recent developments in the diagnosis and treatment of ocular toxoplasmosis. Ophthalmic research, 2017. 57(1): p. 1-12.

Passos, A.D.C.B., Valdes Roberto Furtado, João Marcelo Fortes Lucena, Moisés Moura de Bellissimo-Rodrigues, Fernando Paula, Jayter Silva Melo, Laura Valdiane Luz Rodrigues, Maria de Lourdes Veronese, Prevalence and risk factors of toxoplasmosis among adults in a small Brazilian city. Revista da Sociedade Brasileira de Medicina Tropical, 2018. 51: p. 781-787.

Petersen, E., A. Kijlstra, and M. Stanford, Epidemiology of ocular toxoplasmosis. Ocular immunology and inflammation, 2012. 20(2): p. 68-75.

Rothova, A.S.-v.S., MS Treffers, W Frits Kijlstra, Aize, Causes and frequency of blindness in patients with intraocular inflammatory disease. British Journal of Ophthalmology, 1996. 80(4): p. 332-336.

Samudio, M.A., M Eugenia Castillo, Verónica Guillén, Yvalena Licitra, Gizel Aria, LauraCibils, Pablo Rojas, Alejandra Cibils, Dógenes Meza, Teresa, Aspectos clínico-epidemiológicos de la toxoplasmosis en pacientes que consultan por problemas de visión. Revista chilena de infectología, 2015. 32(6): p. 658-663.

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). The COVID-19 pandemic. International Journal of Health Sciences, 5(2), vi-ix. https://doi.org/10.53730/ijhs.v5n2.2937

Tomasi, J.-P., A.-F. Schlit, and S. Stadtsbaeder, Rapid double-sandwich enzyme-linked immunosorbent assay for detection of human immunoglobulin M anti-Toxoplasma gondii antibodies. Journal of clinical microbiology, 1986. 24(5): p. 849-850.

Published

25-08-2022

How to Cite

Karim, D. O., Azeez, K. H., & Abdullah, Y. S. (2022). Seroprevalence of Toxoplasma gondii among ocular infection patient in Shahid Dr. Aso Hospital in Sulaimani City, Iraq. International Journal of Health Sciences, 6(S9), 31–39. https://doi.org/10.53730/ijhs.v6nS9.12165

Issue

Section

Peer Review Articles